Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-111899
Filing Date
2024-10-28
Accepted
2024-10-28 18:08:43
Documents
1
Group Members
ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLCATLAS VENTURE ASSOCIATES X, L.P.ATLAS VENTURE ASSOCIATES X, LLCATLAS VENTURE OPPORTUNITY FUND I, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2426988d1_sc13da.htm SC 13D/A 119752
  Complete submission text file 0001104659-24-111899.txt   121835
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Fund X, L.P. (Filed by) CIK: 0001628098 (see all company filings)

EIN.: 472435989 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472 (339) 666-3320
Tectonic Therapeutic, Inc. (Subject) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90532 | Film No.: 241402165
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)